Ridgefield, CT, United States of America

Kathleen Last-Barney

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Kathleen Last-Barney

Introduction

Kathleen Last-Barney is a notable inventor based in Ridgefield, CT (US). She has made significant contributions to the field of biotechnology, particularly in the development of compounds targeting specific proteins involved in inflammatory processes. With a total of three patents to her name, her work has implications for therapeutic applications.

Latest Patents

Kathleen Last-Barney's latest patents include a compound targeting IL-23A and TNF-alpha, along with their uses. The disclosure relates to compounds that are specific for IL-23A and TNF-alpha, as well as compositions that comprise these compounds. Additionally, methods of use, nucleic acids, cells, and methods of production related to these compounds and compositions are also disclosed.

Career Highlights

Throughout her career, Kathleen has worked with prominent companies in the biotechnology sector, including Boehringer Ingelheim International GmbH and Macrogenics, Inc. Her experience in these organizations has allowed her to develop and refine her innovative ideas.

Collaborations

Some of her notable coworkers include Rachel Rebecca Barrett and Leslie Sydnor Johnson. Their collaborative efforts have contributed to the advancement of research and development in their respective fields.

Conclusion

Kathleen Last-Barney's work exemplifies the impact of innovation in biotechnology. Her patents and collaborations highlight her commitment to advancing medical science through targeted therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…